Skip to main content


Page 1 of 70

  1. Patients undergoing radiation therapy (RT) often experience anxiety, which may jeopardize the treatment success. The efficacy of music interventions in reducing anxiety remains contentious. This randomized tri...

    Authors: Huei-Fan Yang, Wen-Wei Chang, Ying-Hsiang Chou, Jing-Yang Huang, Yu-Shiun Liao, Ting-En Liao, Hsien-Chun Tseng, Shih-Tsung Chang, Hsin Lin Chen, Ya-Fang Ke, Pei-Fang Tsai, Hsiu-Man Chan, Bo-Jiun Chang, Yi-Ting Hwang, Hsueh-Ya Tsai and Yueh-Chun Lee
    Citation: Radiation Oncology 2024 19:73
  2. To integrate radiomics and dosiomics features from multiple regions in the radiation pneumonia (RP grade ≥ 2) prediction for esophageal cancer (EC) patients underwent radiotherapy (RT).

    Authors: Chenyu Li, Ji Zhang, Boda Ning, Jiayi Xu, Zhixi Lin, Jicheng Zhang, Ninghang Tan, Xianwen Yu, Wanyu Su, Weihua Ni, Wenliang Yu, Jianping Wu, Guoquan Cao, Zhuo Cao, Congying Xie and Xiance Jin
    Citation: Radiation Oncology 2024 19:72
  3. Particle therapy makes a noteworthy contribution in the treatment of tumor diseases. In order to be able to irradiate from different angles, usually expensive, complex and large gantries are used. Instead rota...

    Authors: Cedric Beyer, Katharina Maria Paul, Stefan Dorsch, Gernot Echner, Fabian Dinkel, Thomas Welzel, Katharina Seidensaal, Juliane Hörner-Rieber, Oliver Jäkel, Jürgen Debus and Sebastian Klüter
    Citation: Radiation Oncology 2024 19:71
  4. To investigate the efficacy of 125I seed brachytherapy for non-central pelvic recurrence of cervical cancer after external beam radiotherapy, and to analyze the clinical influential factors.

    Authors: Xuemin Di, Zhen Gao, Huimin Yu, Xiaoli Liu, Jinxin Zhao, Juan Wang and Hongtao Zhang
    Citation: Radiation Oncology 2024 19:70
  5. Multiple artificial intelligence (AI)-based autocontouring solutions have become available, each promising high accuracy and time savings compared with manual contouring. Before implementing AI-driven autocont...

    Authors: Lee Goddard, Christian Velten, Justin Tang, Karin A. Skalina, Robert Boyd, William Martin, Amar Basavatia, Madhur Garg and Wolfgang A. Tomé
    Citation: Radiation Oncology 2024 19:69
  6. Approximately 25–50% of patients undergoing radiotherapy (RT) experience psychological distress and anxiety, which can detrimentally affect both their quality of life and treatment outcomes. While previous res...

    Authors: Rebecca Moser, Nina A. Mayr, Jana Nano, Sophie T. Behzadi, Sophia Kiesl, Stephanie E. Combs and Kai J. Borm
    Citation: Radiation Oncology 2024 19:68
  7. First-line chemotherapy combined with bevacizumab is one of the standard treatment modes for patients with advanced non-small cell lung cancer (NSCLC). Thoracic radiotherapy (TRT) can provide significant local...

    Authors: Feihu Chen, Jiling Niu, Min Wang, Hui Zhu and Zhijun Guo
    Citation: Radiation Oncology 2024 19:67
  8. Accurate segmentation of the clinical target volume (CTV) of CBCT images can observe the changes of CTV during patients' radiotherapy, and lay a foundation for the subsequent implementation of adaptive radioth...

    Authors: Ziyi Wang, Nannan Cao, Jiawei Sun, Heng Zhang, Sai Zhang, Jiangyi Ding, Kai Xie, Liugang Gao and Xinye Ni
    Citation: Radiation Oncology 2024 19:66
  9. Local treatment options for locally recurrent pancreatic adenocarcinoma (LR-PAC) are limited, with median survival time (MST) of 9–13 months (mos) following recurrence. MRI-guided stereotactic body radiation t...

    Authors: Spencer J. Poiset, Sophia Shah, Louis Cappelli, Pramila Anné, Karen E. Mooney, Maria Werner-Wasik, Talya S. Laufer, James A. Posey, Daniel Lin, Atrayee Basu Mallick, Harish Lavu, Babar Bashir, Charles J. Yeo and Adam C. Mueller
    Citation: Radiation Oncology 2024 19:65
  10. This study aims to investigate the effects of chest wall bolus in intensity-modulated radiotherapy (IMRT) technology on clinical outcomes for post-mastectomy breast cancer patients.

    Authors: Tao Jiang, Jiao Tian, Peijie Lei, Chunliu Meng, Jialei Fu, Lianjing Cao, Jingjing Cheng, Fei Zhou, Hongjun Zhang, Hao Song, Haijun Lu and Xiaojuan Wei
    Citation: Radiation Oncology 2024 19:64
  11. The most common route of breast cancer metastasis is through the mammary lymphatic network. An accurate assessment of the axillary lymph node (ALN) burden before surgery can avoid unnecessary axillary surgery,...

    Authors: Ranze Cai, Li Deng, Hua Zhang, Hongwei Zhang and Qian Wu
    Citation: Radiation Oncology 2024 19:63
  12. The effectiveness and safety of moderately hypofractionated radiotherapy (HFRT) in patients undergoing breast-conserving surgery (BCS) has been demonstrated in several pivotal randomized trials. However, the f...

    Authors: Kairui Jin, Jurui Luo, Xiaoli Yu and Xiaomao Guo
    Citation: Radiation Oncology 2024 19:62
  13. Accurate deformable registration of magnetic resonance imaging (MRI) scans containing pathologies is challenging due to changes in tissue appearance. In this paper, we developed a novel automated three-dimensi...

    Authors: Alexander F. I. Osman, Kholoud S. Al-Mugren, Nissren M. Tamam and Bilal Shahine
    Citation: Radiation Oncology 2024 19:61
  14. The brachytherapy is an indispensable treatment for gynecological tumors, but the quality and efficiency of brachytherapy training for residents is still unclear.

    Authors: Mohan Dong, Changhao Liu, Junfang Yan, Yong Zhu, Yutian Yin, Jia Wang, Ying Zhang, Lichun Wei and Lina Zhao
    Citation: Radiation Oncology 2024 19:60
  15. Malignant phyllodes tumor of the breast (MPTB) is a rare type of breast cancer, with an incidence of less than 1%. The value of adjuvant radiotherapy (RT) for MPTB has been controversial. The aim of the study ...

    Authors: Ping Yang, Gongyin Zhang, Yu Zhang, Wanying Zhao, Jinhai Tang, Siyuan Zeng, Xiupeng Lv and Li Lv
    Citation: Radiation Oncology 2024 19:59
  16. Authors: Philip Blumenfeld, Eduard Arbit, Robert Den, Ayman Salhab, Tal Falick Michaeli, Marc Wygoda, Yair Hillman, Raphael M. Pfeffer, Marcel Fang, Yael Misrati, Noam Weizman, Jon Feldman and Aron Popovtzer
    Citation: Radiation Oncology 2024 19:57

    The original article was published in Radiation Oncology 2024 19:43

  17. Oncologic surgical resection is the standard of care for extremity and truncal soft tissue sarcoma (STS), often accompanied by the addition of pre- or postoperative radiation therapy (RT). Preoperative RT may ...

    Authors: Emile Gogineni, Hao Chen, Chen Hu, Karim Boudadi, Jessica Engle, Adam Levine and Curtiland Deville Jr
    Citation: Radiation Oncology 2024 19:56
  18. Stereotactic ablative body radiotherapy (SABR) is an emerging treatment alternative for patients with localized low and intermediate risk prostate cancer patients. As already explored by some authors in the co...

    Authors: Almudena Zapatero, Pablo Castro, María Roch, Pablo Rodríguez Carnero, Sara Carroceda, Alexandra Elena Stoica Rosciupchin, Sergio Honorato Hernández, Leopoldo Cogorno, Alfonso Gómez Iturriaga and David Büchser García
    Citation: Radiation Oncology 2024 19:54
  19. The number of older adults with head and neck squamous cell carcinoma (HNSCC) is continuously increasing. Older HNSCC patients may be more vulnerable to radiotherapy-related toxicities, so that extrapolation o...

    Authors: Helena C. Bitz, Ilias Sachpazidis, Jiadai Zou, Daniel Schnell, Dimos Baltas, Anca-Ligia Grosu, Nils H. Nicolay and Alexander Rühle
    Citation: Radiation Oncology 2024 19:53
  20. Oligo-progression or further recurrence is an open issue in the multi-integrated management of oligometastatic disease (OMD). Re-irradiation with stereotactic body radiotherapy (re-SBRT) technique could repres...

    Authors: Giuditta Chiloiro, Giulia Panza, Luca Boldrini, Angela Romano, Lorenzo Placidi, Matteo Nardini, Matteo Galetto, Claudio Votta, Maura Campitelli, Francesco Cellini, Mariangela Massaccesi and Maria Antonietta Gambacorta
    Citation: Radiation Oncology 2024 19:52
  21. Radiation-induced liver damage (RILD) occasionally occurs following carbon-ion radiotherapy (CIRT) for liver tumors, such as hepatocellular carcinoma (HCC), in patients with impaired liver function disease. Ho...

    Authors: Kazuhiko Hayashi, Osamu Suzuki, Yushi Wakisaka, Koji Ichise, Hirofumi Uchida, Makoto Anzai, Azusa Hasegawa, Yuji Seo, Shinichi Shimizu, Takayoshi Ishii, Teruki Teshima, Jiro Fujimoto and Kazuhiko Ogawa
    Citation: Radiation Oncology 2024 19:51
  22. Stereotactic ablative radiotherapy (SABR) is the standard treatment for medically inoperable early-stage non-small cell lung cancer (ES-NSCLC), but which patients benefit from stereotactic radiotherapy is uncl...

    Authors: Kamila Resova, Lukas Knybel, Tereza Parackova, Marian Rybar, Karel Cwiertka and Jakub Cvek
    Citation: Radiation Oncology 2024 19:50
  23. This study evaluates various craniospinal irradiation (CSI) techniques used in Turkish centers to understand their advantages, disadvantages and overall effectiveness, with a focus on enhancing dose distribution.

    Authors: Öznur Şenkesen, Evrim Tezcanlı, Fadime Alkaya, Burçin İspir, Serap Çatlı, Abdullah Yeşil, Ebrar Bezirganoglu, Sezgi Turan, Canan Köksal, Gülay Güray, Emel Hacıislamoğlu, İsmail Faruk Durmuş, Şeyma Çavdar, Telat Aksu, Nurten Çolak, Esra Küçükmorkoç…
    Citation: Radiation Oncology 2024 19:49
  24. Tumor regression and organ movements indicate that a large margin is used to ensure target volume coverage during radiotherapy. This study aimed to quantify inter-fractional movements of the uterus and cervix ...

    Authors: Zheng Zeng, Jiawei Zhu, Zhiqun Wang, Guangyu Wang, Junfang Yan and Fuquan Zhang
    Citation: Radiation Oncology 2024 19:48
  25. Small cell lung cancer (SCLC) is highly invasive with poor prognosis, and its treatment has historically been hindered due to the absence of targetable driver genomic alterations. However, the high genomic ins...

    Authors: Jiuang Mao, Jianjiao Ni, Li Chu, Xiao Chu, Dayu Xu, Xi Yang and Zhengfei Zhu
    Citation: Radiation Oncology 2024 19:47
  26. To evaluate effects of bone marrow sparing (BMS) radiotherapy on decreasing the incidence of acute hematologic toxicity (HT) for locoregionally advanced cervical cancer (LACC) patients treated by pelvic irradi...

    Authors: Wen Li, Lan Ma, Fang Li, Kemin Li, Yang Zhang, Hongtao Ren, Xing Bao, Yuyan Guo, Ya Guo, Mincong Wang, Dan Li, Yuanqiong Duan, Xiulong Ma, Zhongwei Wang, Yali Wang and Rutie Yin
    Citation: Radiation Oncology 2024 19:46
  27. Current automated planning solutions are calibrated using trial and error or machine learning on historical datasets. Neither method allows for the intuitive exploration of differing trade-off options during c...

    Authors: Philip A Wheeler, Nicholas S West, Richard Powis, Rhydian Maggs, Michael Chu, Rachel A Pearson, Nick Willis, Bartlomiej Kurec, Katie L. Reed, David G. Lewis, John Staffurth, Emiliano Spezi and Anthony E. Millin
    Citation: Radiation Oncology 2024 19:45
  28. Fibroblast activation protein (FAP) is expressed in the tumor microenvironment (TME) of various cancers. In our analysis, we describe the impact of dual-tracer imaging with Gallium-68-radiolabeled inhibitors o...

    Authors: Simone Wegen, Karina Claus, Philipp Linde, Johannes Rosenbrock, Maike Trommer, Thomas Zander, Armin Tuchscherer, Christiane Bruns, Hans Anton Schlößer, Wolfgang Schröder, Marie-Lisa Eich, Thomas Fischer, Klaus Schomäcker, Alexander Drzezga, Carsten Kobe, Katrin Sabine Roth…
    Citation: Radiation Oncology 2024 19:44
  29. Adaptive radiation therapy (ART) offers a dynamic approach to address structural and spatial changes that occur during radiotherapy (RT) for locally advanced head and neck cancers. The integration of daily ART...

    Authors: Philip Blumenfeld, Eduard Arbit, Robert Den, Ayman Salhab, Tal Falick Michaeli, Marc Wygoda, Yair Hillman, Raphael M. Pfeffer, Marcel Fang, Yael Misrati, Noam Weizman, Jon Feldman and Aron Popovtzer
    Citation: Radiation Oncology 2024 19:43

    The Correction to this article has been published in Radiation Oncology 2024 19:57

  30. Solitary fibrous tumors (SFT) of the central nervous system are rare and treatment options are not well established. The aim of this study was to evaluate the clinical outcomes of radiotherapy (RT) and re-radi...

    Authors: Mike Ton, Maximilian Deng, Eva Meixner, Tanja Eichkorn, Anna Krämer, Katharina Seidensaal, Juliane Hörner-Rieber, Jonathan Lischalk, Klaus Herfarth, Jürgen Debus and Laila König
    Citation: Radiation Oncology 2024 19:42
  31. To assess a large panel of MR compatible detectors on the full range of measurements required for a 0.35 T MR-linac commissioning by using a specific statistical method represented as a continuum of comparison...

    Authors: Michel Chea, Mathilde Croisé, Christelle Huet, Céline Bassinet, Mohamed-Amine Benadjaoud and Catherine Jenny
    Citation: Radiation Oncology 2024 19:40
  32. At present, the implementation of intensity-modulated radiation therapy (IMRT) treatment planning for geometrically complex nasopharyngeal carcinoma (NPC) through manual trial-and-error fashion presents challe...

    Authors: Wenwen Cai, Shouliang Ding, Huali Li, Xuanru Zhou, Wen Dou, Linghong Zhou, Ting Song and Yongbao Li
    Citation: Radiation Oncology 2024 19:39
  33. The addition of radiation therapy (RT) to surgery in retroperitoneal sarcoma (RPS) remains controversial. We examined practice patterns in the use of RT for patients with RPS over time in a large, national coh...

    Authors: Samantha M. Ruff, Victor Heh, David J. Konieczkowski, Amblessed Onuma, Hayley M. Dunlop, Alex C. Kim, Valerie P. Grignol, Carlo M. Contreras, Timothy M. Pawlik, Raphael Pollock and Joal D. Beane
    Citation: Radiation Oncology 2024 19:38
  34. Magnetic resonance imaging (MRI) plays an increasingly important role in radiotherapy, enhancing the accuracy of target and organs at risk delineation, but the absence of electron density information limits it...

    Authors: Changfei Gong, Yuling Huang, Mingming Luo, Shunxiang Cao, Xiaochang Gong, Shenggou Ding, Xingxing Yuan, Wenheng Zheng and Yun Zhang
    Citation: Radiation Oncology 2024 19:37
  35. Treatment related lymphopenia is a known toxicity for glioblastoma (GBM) patients and several single-institution studies have linked lymphopenia with poor survival outcomes. We performed a systematic review an...

    Authors: Ali M. Saeed, Søren M. Bentzen, Haroon Ahmad, Lily Pham, Graeme F. Woodworth and Mark V. Mishra
    Citation: Radiation Oncology 2024 19:36

    The Correction to this article has been published in Radiation Oncology 2024 19:58

  36. Diffusion-weighted magnetic resonance imaging (DWI) provides a measurement of tumor cellularity. We evaluated the potential of apparent diffusion coefficient (ADC) values obtained from post-external beam radia...

    Authors: Elizabeth E. Dong, Junqian Xu, Joo-Won Kim, Jason Bryan, Jewel Appleton, Daniel A. Hamstra, Michelle S. Ludwig and Alexander N. Hanania
    Citation: Radiation Oncology 2024 19:35
  37. FLASH therapy is a treatment technique in which radiation is delivered at ultra-high dose rates ( 40 Gy/s). The first-in-human FAST-01 clinical trial demonstrated the clinical feasibility of proton FLASH in the ...

    Authors: EC Daugherty, Y Zhang, Z Xiao, AE Mascia, M Sertorio, J Woo, C McCann, KJ Russell, RA Sharma, D Khuntia, JD Bradley, CB Simone 2nd, JC Breneman and JP Perentesis
    Citation: Radiation Oncology 2024 19:34
  38. Radiotherapy (RT) is an important treatment modality for patients with brain malignancies. Traditionally, computed tomography (CT) images are used for RT treatment planning whereas magnetic resonance imaging (...

    Authors: Johanna Grigo, Juliane Szkitsak, Daniel Höfler, Rainer Fietkau, Florian Putz and Christoph Bert
    Citation: Radiation Oncology 2024 19:33
  39. Centrally located lung tumours present a challenge because of their tendency to exhibit symptoms such as airway obstruction, atelectasis, and bleeding. Surgical resection of these tumours often requires sacrif...

    Authors: Noriko Kishi, Masahiro Yoneyama, Hiroyuki Inoo, Minoru Inoue, Hiraku Iramina, Akiyoshi Nakakura, Tomohiro Ono, Hideaki Hirashima, Takanori Adachi, Norimasa Matsushita, Makoto Sasaki, Takahiro Fujimoto, Mitsuhiro Nakamura, Yukinori Matsuo and Takashi Mizowaki
    Citation: Radiation Oncology 2024 19:32
  40. Longitudinal assessments of apparent diffusion coefficients (ADCs) derived from diffusion-weighted imaging (DWI) during intracranial radiotherapy at magnetic resonance imaging-guided linear accelerators (MR-li...

    Authors: Moritz Rabe, Olaf Dietrich, Robert Forbrig, Maximilian Niyazi, Claus Belka, Stefanie Corradini, Guillaume Landry and Christopher Kurz
    Citation: Radiation Oncology 2024 19:31
  41. Intensity-modulated radiation therapy (IMRT) is considered standard of care for head and neck squamous cell carcinoma (HNSCC). Improved conformity of IMRT and smaller margins, however, have led to concerns of ...

    Authors: Paul-Henry Mackeprang, Katarina Bryjova, Astrid E. Heusel, Dominik Henzen, Melissa Scricciolo and Olgun Elicin
    Citation: Radiation Oncology 2024 19:30
  42. Percentage of positive cores involved on a systemic prostate biopsy has been established as a risk factor for adverse oncologic outcomes and is a National Comprehensive Cancer Network (NCCN) independent parame...

    Authors: Jonathan W. Lischalk, Astrid Sanchez, Vianca F. Santos, Christopher Mendez, Meredith Akerman, Todd Carpenter, Moses Tam, David Byun, David R. Wise, Anand Mahadevan, Andrew Evans, William Huang, Aaron Katz, Herbert Lepor and Jonathan A. Haas
    Citation: Radiation Oncology 2024 19:29
  43. To assess the tolerability and oncological results of chemoradiation in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction.

    Authors: Tilman Bostel, Eirini Nikolaidou, Daniel Wollschläger, Arnulf Mayer, Justus Kaufmann, Anne Hopprich, Alexander Rühle, Anca-Ligia Grosu, Jürgen Debus, Christian Fottner, Markus Moehler, Peter Grimminger, Heinz Schmidberger and Nils Henrik Nicolay
    Citation: Radiation Oncology 2024 19:28
  44. The incorporation of magnetic resonance (MR) imaging in radiotherapy (RT) workflows improves contouring precision, yet it introduces geometrical uncertainties when registered with computed tomography (CT) scan...

    Authors: Elia Rossi, Sevgi Emin, Michael Gubanski, Giovanna Gagliardi, Mattias Hedman and Fernanda Villegas
    Citation: Radiation Oncology 2024 19:27
  45. Xerostomia is one of the most common side effects in nasopharyngeal carcinoma (NPC) patients after chemoradiotherapy. To establish a Delta radiomics model for predicting xerostomia secondary to chemoradiothera...

    Authors: Mengze Wang, Yuzhen Xi, Luoyu Wang, Haonan Chen, Feng Jiang and Zhongxiang Ding
    Citation: Radiation Oncology 2024 19:26
  46. Platinum-etoposide chemotherapy combined with immune checkpoint inhibitors (ICIs) has been recommended as the first-line standard treatment for extensive-stage small-cell lung cancer (ES-SCLC). However, the ef...

    Authors: Yueyuan Yao, Butuo Li, Ruiting Song, Linlin Yang, Bing Zou and Linlin Wang
    Citation: Radiation Oncology 2024 19:25
  47. Radioresistance is one of the barriers to developing more effective therapies against the most aggressive, triple-negative, breast cancer (TNBC) subtype. In our previous studies, we showed that inhibition of P...

    Authors: Sierra Pellizzari, Vasudeva Bhat, Harjot Athwal, David W. Cescon, Alison L. Allan and Armen Parsyan
    Citation: Radiation Oncology 2024 19:24

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    605 Altmetric mentions